GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Construction In Progress

Control Bionics (ASX:CBL) Construction In Progress : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Construction In Progress?

Control Bionics's annual construction in progress declined from Jun. 2022 (A$0.05 Mil) to Jun. 2023 (A$0.00 Mil) and declined from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil).

Control Bionics Construction In Progress Historical Data

The historical data trend for Control Bionics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics Construction In Progress Chart

Control Bionics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Construction In Progress
- 0.05 - -

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Construction In Progress Get a 7-Day Free Trial Premium Member Only - - - - -

Control Bionics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Control Bionics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Construction In Progress
Comparable Companies
ASX:HMD ASX:AT1 ASX:IRX ASX:ADRDA ASX:UCM ASX:UBI ASX:OSL ASX:CDX ASX:LDX ASX:NTI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Website
https://www.controlbionics.com
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.